M Tripathi, A Kumar, C Bal - Neurology India, 2018 - journals.lww.com
Neuroimaging (NI) in Parkinson's disease (PD) includes functional techniques like positron emission tomography (PET) and single photon emission computed tomography (SPECT) …
S Kõks, AL Pfaff, LM Singleton… - Experimental …, 2022 - journals.sagepub.com
The pathophysiology of Parkinson's disease (PD) is a complex process of the interaction between genetic and environmental factors. Studies on the genetic component of PD have …
GN Stormezand, LT Chaves, DV García, J Doorduin… - NeuroImage: Clinical, 2020 - Elsevier
Abstract Aim L-3, 4-dihydroxy-6–18F-fluorophenylalanine (18F-DOPA PET may be used to distinguish subjects with Parkinsonism from those with symptoms not originating from …
Purpose The role of mesocortical dopaminergic pathways in the cognitive function of patients with early Parkinson's disease (PD) needs to be further clarified. Methods The study …
SR Toch, S Poussier, E Micard, M Bertaux… - Molecular imaging and …, 2019 - Springer
Abstract Purpose 6-[18 F] fluoro-l-DOPA ([18 F] FDOPA), a positron emission tomography (PET) amino-acid tracer of brain decarboxylase activity, is used to assess the brain …
In Parkinson's disease (PD) degeneration of mesocortical dopaminergic projections may determine cognitive and behavioral symptoms. Choice reaction time task is related to …
I Lopes Alves, SK Meles… - Journal of Cerebral …, 2017 - journals.sagepub.com
The Patlak graphical analysis (PGAREF) for quantification of irreversible tracer binding with a reference tissue model was approximated by a dual time point imaging approach …
Malignant cells reprogram metabolic pathways to meet the demands of growth and proliferation. These altered manners of metabolism are now identified as hallmarks of …